Pioglitazone Tablet
Product Images NDC 42291-961

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Pioglitazone (NDC 42291-961). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (959 30)

Packaging label for Pioglitazone Tablets, USP 15 mg by AvKARE. The label states the product is for prescription use, contains 30 tablets per bottle, and includes dispensing instructions for pharmacists. Additional storage and safety information is also visible, along with a barcode and NDC number 42291-959-30.*

FDA Label Image

2 (959 90)

Packaging label for Pioglitazone Tablets, USP 15 mg oral tablets by AvKARE. The label indicates a package size of 90 tablets and states 'Rx Only.' It includes usage instructions, storage conditions, a barcode, and warnings about keeping the medication out of reach of children.*

FDA Label Image

3 (960 30)

Pioglitazone Tablets USP 30 mg oral tablets label by AvKARE. The label indicates a package containing 30 tablets, with dispensing instructions for pharmacists and storage conditions. It includes the NDC 42291-960-30 and a barcode.*

FDA Label Image

4 (960 90)

Pioglitazone Tablets USP 30 mg oral tablet label from AvKARE. The label includes storage instructions, a warning to keep the medication out of reach of children, the quantity of 90 tablets, and dispensing guidance for pharmacists. The NDC number and a barcode are present on the label.*

FDA Label Image

5 (961 30)

Pioglitazone Tablets USP 45 mg oral tablets by AvKARE. The label shows a package containing 30 tablets, with instructions to dispense the accompanying medication guide to each patient. The label includes storage instructions and warnings to keep the medication out of reach of children.*

FDA Label Image

6 (961 50)

Pioglitazone Tablets, USP 45 mg oral tablets by AvKARE. The label features the AvKARE logo, NDC 42291-961-50, and specifies 'Rx Only.' The package provides pharmacist instructions to dispense the accompanying medication guide, and lists active ingredient pioglitazone hydrochloride. It includes handling and storage information, barcode, and manufacturing details from AvKARE in Malvern, Arkansas.*

FDA Label Image

Chemical Structure (Image 1)

Chemical structure of Pioglitazone hydrochloride, showing its molecular configuration including aromatic rings, sulfur-containing thiazolidinedione ring, and hydrochloride component.*

FDA Label Image

Figure 1 (Image 2)

A line graph comparing the mean values over a 26-week period for placebo and three dosages of Pioglitazone tablets: 15 mg, 30 mg, and 45 mg. The x-axis represents time in weeks, and the y-axis represents the mean value. Different colored markers and lines denote placebo, 15 mg, 30 mg, and 45 mg groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.